Description

Simple

Clinical

Overview

Pharmacology

Indication

Investigated for use/treatment in fungal infections, aspergillosis, candidiasis, and onychomycosis.

Pharmacodynamic

Information currently not available.

Mechanism of action

Information currently not available.

Absorption

Information currently not available.

Protein binding

Information currently not available.

Volume of distribution

Information currently not available.

Clearance

Information currently not available.

Half life

Information currently not available.

Route of elimination

Information currently not available.

Toxicity

Information currently not available.

Adverse Effects

Contraindications

Information currently not available.

Food Interactions

    Information currently not available.

Interactions

Type in a drug name to check for interaction with Ravuconazole
Type a drug name in the box above to get started
  • Paracetamol(acetaminophen)
  • Paxil(paroxetine)
  • Pamelor(nortriptyline)
  • Panadol(acetaminophen)
  • Patanol(olopatadine ophthalmic)
  • Pataday(olopatadine ophthalmic)
  • Parnate(tranylcypromine)
  • Pazeo(olopatadine ophthalmic)
(R)-warfarin
The therapeutic efficacy of (R)-warfarin can be increased when used in combination with Ravuconazole.
(S)-Warfarin
The therapeutic efficacy of (S)-Warfarin can be increased when used in combination with Ravuconazole.
4-hydroxycoumarin
The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Ravuconazole.
Acenocoumarol
The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Ravuconazole.
Agmatine
The therapeutic efficacy of Ravuconazole can be increased when used in combination with Agmatine.
Almasilate
Almasilate can cause a decrease in the absorption of Ravuconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aloglutamol
Aloglutamol can cause a decrease in the absorption of Ravuconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminium
Aluminium can cause a decrease in the absorption of Ravuconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminium acetoacetate
Aluminium acetoacetate can cause a decrease in the absorption of Ravuconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminium glycinate
Aluminium glycinate can cause a decrease in the absorption of Ravuconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminium phosphate
Aluminium phosphate can cause a decrease in the absorption of Ravuconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Ravuconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Amiodarone
The therapeutic efficacy of Ravuconazole can be increased when used in combination with Amiodarone.
Amlodipine
The therapeutic efficacy of Ravuconazole can be increased when used in combination with Amlodipine.
Amphotericin B
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Ravuconazole.
Aranidipine
The therapeutic efficacy of Ravuconazole can be increased when used in combination with Aranidipine.
Asenapine
Asenapine can cause a decrease in the absorption of Ravuconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Atorvastatin
The risk or severity of myopathy can be increased when Ravuconazole is combined with Atorvastatin.
Azelnidipine
The therapeutic efficacy of Ravuconazole can be increased when used in combination with Azelnidipine.
Barnidipine
The therapeutic efficacy of Ravuconazole can be increased when used in combination with Barnidipine.